Scholarship and Teaching
(October
2009)
I. Publications
Original Papers
[1] Bashey RI, Philips N,
Insigna F, Jimenez SA. (1993) Increased
collagen
synthesis and increased content of type VI collagen in
myocardium of tight skin mice. Cardiovascular
Res 27:1061-1065.
[2] Philips N, Bashey RI, Jimenez SA. (1994) Collagen
and fibronectin expression by cardiac fibroblasts from hypertensive rats. Cardiovascular Res 28: 1341-1347.
[3] Philips N, Bashey R,
Jimenez SA. (1995) Increased a1 (I) procollagen gene
expression in tight skin (TSK) mice myocardial fibroblasts is due to the
absence of the strong inhibitory effect of a negative regulatory sequence that
interacts with AP-1 transcription factor. J
Biol Chem 270: 9313-9321.
[4] Philips N, Onwubalili N.
(2002) Anti transforming growth factor-beta (TGF-b) increases
the expressions of matrix metalloproteinase-1 (MMP-1) and growth factors in a
renal adenocarcinoma cell line. Bios 73: 86-90.
[5] Philips N, Smith J, Keller T, Gonzalez S.
(2003) Predominant effects of Polypodium leucotomos on membrane
integrity, lipid peroxidation, and expression of elastin and
matrixmetalloproteinase-1 in ultraviolet radiation exposed fibroblasts, and
keratinocytes. J Dermatol Sci 32: 1-9.
[6] Philips N. (2003) An anti
TGF-b increased the
expression of transforming growth factor-b, matrix metallproteinase-1, and elastin, and its
effects were antagonized by ultraviolet radiation in epidermal keratinocytes. J Dermatol Sci 33: 177-179.
[7] Philips N, Devaney J. (2003) Beneficial Regulation of
Type I Collagen and Matrixmetalloproteinase –1 Expression by Estrogen,
Progesterone, and its Combination in Skin Fibroblasts. J Am Aging Association 26: 59-62.
[8] Philips N, Keller T,
Gonzalez S. (2004) TGF b like regulation of matrix mettalloproteinases by anti
transforming growth factor-b and anti transforming growth factor-b1 antibodies in dermal fibroblasts: implications to
wound healing. Wound Rep Reg 12:
53-59.
[9] Philips N, McFadden K. (2004) Inhibition of transforming
growth factor-beta and matrix metalloproteinases by estrogen, and prolactin in
breast cancer cells. Cancer Letters
206: 63-68.
[10] Philips N, Burchill D,
O’Donoghue D, Keller T, Gonzalez S. (2004) Identification of benzene
metabolites in dermal fibroblasts: Regulation of cell viability, apoptosis,
lipid peroxidation, and expression of MMP-1 and elastin by benzene metabolites.
Skin Pharmacol and Physiol 17:
147-152.
[11] Philips N, Keller T, Holmes C. (2007) Reciprocal Effects of Ascorbate on Cancer Cell Growth and the Expression of Matrix Metalloproteinases and Transforming Growth Factor-beta. Cancer Letters 256: 49-55.
[12] Philips N, Keller T, Hendrix C, Hamilton S, Arena R, Tuason M, Gonzalez S. (2007) Regulation of the Extracellular Matrix Remodeling by Lutein in Dermal Fibroblasts, Melanoma cells, and Ultraviolet Radiation Exposed Fibroblasts. Arch Dermatol Res 299: 373-379.
[13] Astner S, Wu A, Chen J, Philips N, Rius-Diaz F, Parrado C, Mihm MC, Goukassian DA, Pathak MA, González, S. (2007) Dietary Lutein/Zeaxanthin Reduces Photoaging and Photocarcinogenesis in Chronically UVB Irradiated SKH -1 Hairless Mice. Skin Pharmacol and Physiol 20: 283-281.
[14] Brieva A, Philips N, Tejedor R, Guerrero A, Pivel JP, Alonso-Lebrero JL, Gonzalez S. (2008) Molecular Basis for the Regenertive Properties of the Mollusk Criptomphalus aspersa. Skin Pharmacol and Physiol 21:15-22.
[16] Philips N, Tahir M, Stellatella J, Stephan K, Givant J, Zhou L, Costa A, Taw M (2009) Differential Regulation of Growth Factors and Matrix Metalloproteinase-1 by Estrogen, Progesterone, and Tamoxifen in Normal and Cancerous Endometrial cells. J. Cancer Mol. 4: 169-173.
[17] Philips N,
Tuason M, Chang T, Lin Y, Tahir M, Rodriguez SG (2009)
Differential effects of Ceramide on Cell Viability and Extracellular Matrix
Remodeling in Keratinocytes and Fibroblasts. Skin Parmacol. Physiol. 22:151-157.
[18] Philips N, Conte J, Chen Y, Natrajan P, Taw M, Keller T, Givant J, Tuason M, Dulaj L, Leonardi D, Gonzalez S (2009) Beneficial Regulation of Matrixmetalloproteinases and its Inhibitors, Fibrillar Collagens and Transforming Growth Factor-b by P. leucotomos, Directly or in Dermal Fibroblasts, Ultraviolet Radiated Fibroblasts, and Melanoma Cells. Arc. Derm. Res.: 301:487-495
[19] Philips N, Dulaj L, Upadhya T. (2009) Growth inhibitory mechanism of ascorbate and counteraction of its Matrix Metalloproteinases-1 and Transforming Growth Factor-beta stimulation by gene silencing or P. leucotomos AntiCancer Research in press.
Book Chapters
[1] Philips N. (1997) Altered expression of collagen and elastic fibers in photodamaged skin. Dermatol Cosmet 2: 129-130.
[2] Philips N. (1998) Molecular effects of
benzene/benzene metabolites on skin cells. Dermatol
Cosmet 8: 97-100.
[3] Resetar
JM. and Philips N. (1998) Clinical pathology and epidemiology of
the Ebola virus:
investigating immune response. Dermatol
Cosmet 8: 113-118.
[4] Koskowicz K. and Philips N. (1999) Extracellular matrix
proteins and its effects on fibroblasts and keratinocytes. Dermatol Cosmet 9: 95-101.
[5] Philips N. and Newman J. (2000) Correlations of cellular senescence with alterations in immune response, and expression of transforming growth factor-beta (TGF-b) and interstitial collagenase. Dermatol Cosmet 10: 15-17.
[6] Editor’s report, (2007). Focus on research. The fern P. leucotomos-From ethnomedicine to documented photoimmunoprotection. Dermatology Focus 25: 16-18
[7] Philips N (2008). Experimental Biochemistry on Skin Anti-Aging. Cosmetiscope 14 (2): 4
[8]
Bautista M, Lockett F, Mecca J, Sawatdeekhachornphat W, Castro A, Yarlagadda S,
Gonzales S, and Philips N. (2008) The use of antisense oligonucleotides in skin
lightening products. J of Plast Dermatol
4: 17-19.
[9]
Goodner J, Patil U, Lim Y, Yarlagadda S, Castro A, Gonzales S, and Philips N.
(2008) Coating on micronized titanium dioxide increases safety and maintains
efficacy as sunscreen filter. J of Plast
Dermatol 4: 21-22.
II. Grant
proposals/Funding and Reports
I. Industrial
Farmaceutica Cantabria (IFC)
(1) Regulation of Extracellular Matrix, Heat Shock Proteins, and Transforming Growth Factor-b (TGF-b) by Polypodium leucotomos (PL) in Preventing Skin Aging (January 2007 − December 2008).
(2) Molecule 168 and Derivatives: Regulation of Extracellular Matrix and Heat Shock Proteins (May 2008 − December 2008).
(3) Improvement of Epidermal Barrier Function by Polypodium leucotomos in Preventing Skin Photo-aging (May 2008 − December 2009).
(4) Anti-inflammatory and Antiangiogenic Mechanism of Polypodium leucotomos (May 2008 − December 2009).
II. Research
Release time,
(1) Regulation of Extracellular Matrix, Heat Shock Proteins, and Transforming Growth Factor-b (TGF-b) by Polypodium leucotomos (PL) in Preventing Skin Aging (Six credits) (September 2007 − May 2008).
(2) Improvement of Epidermal Barrier Function and Prevention of Tumorigenesis by Polypodium leucotomos, via Anti-inflammatory and Anti-angiogenic Mechanisms (Three credits) (January 2010 - May 2010)
III. Grant-in-Aid program,
(1) Investigation of Cancer Mechanisms in an Ascorbate Model: Regulation by Lutein and Specific Gene Silencing (June 2007 − May 2008)
(2) Investigation and Management of Ascorbate Effects in Cancer Treatment (June 2008 − May 2009).
(3) Inhibition of Angiogenesis and Immune Cell Preservation in Cancer Management by Ascorbate and P. leucotomos (July 2009 − June 2010).
IV SEED grant,
(1) Elastin Gene Silencing in Keratinocytes for the Management of Solar Skin Aging (September 2007 − August 2008).
[2] Philips N. (2008). Stimulation of Tissue Inhibitors of Matrixmetalloproteinases, Fibrillins and Survival in Keratinocytes by P. leucotomos
III. Reasearch Methods and Equipment
Research
Methodology:
(1) Cell and tissue culture, Maintenance, and Experimentation in cells or tissue-equivalents; Skin (fibroblasts, keratinocytes, skin equivalents) and cancer (melanoma, renal, mammary, endometrial);
(2) Cell viability, Proliferation, Toxicity and Apoptosis;
(3) Recombinant DNA Technology; Polymerase chain reaction (PCR), Cloning, Site directed mutagenesis;
(4) Transcriptional Regulation: Transfection of promoter-reporter plasmids and
reporter (chloramphenicol acetyl transferase, luciferase, beta-galactosidase) assays;Promoter/protein interactions (Gel shift and super shift assays); (5) mRNA analysis: RNA isolation, Northern blot hybridization, RNase protection, RT- PCR, Real time PCR, RNA interference. (6) Protein analysis: ELISA, Zymograms, Western blotting, Immunoprecipitation;
(7) Oxidative stress: Assays for Reactive oxygen or nitrogen species, Lipid peroxidation
and Antioxidant assays;
(8) Enzyme kinetics and Enzyme activity Inhibition: Matrix metalloproteinases and
Elastase;
(9) Histology: Paraffin embedding, Cryostat, Slide preparation, H&E staining,
Immunohistochemistry,
Immunoflurescence.
Instruments: Tissue
culture Hoods (Baker, Herasafe); Microplate Readers/data analysis - absorbance,
luminescence and fluorescence (Berthold Mithras LB490; Biotek Synergy HT;
Dynex); Electrophoresis (Amersham Multiphor II system, Bio Rad system;
Invitrogen e-PAGE); Imaging (Imgen technologies, alpha ease program); iCycler
iQ (Bio Rad); Microscopes (Inverted; Leica CTR 6000 with fluorescence imaging);
Histology (Leica- Microtom, cryostat, paraffin embedding center).
IV. Presentations/Abstracts
Presentations
[1] Philips N, Bashey RI, Donnelly M and Jimenez SA. (1991)
Increased collagen gene expression in cultured fibroblast-like cells from hypertrophic myocardium Faseb J 5:A1245 (Oral: Annual meeting FASEB, Georgia)
[2] Philips N and Blumemberg M. (1998) Regulation of expression of elastin, collagenase and type I collagen in keratinocytes, fibroblasts and co-cultures of keratinocytes and fibroblasts. Bull NJ Acad Sci 43 (Oral: Annual meeting New Jersey Academy of Science, New Jersey)
[3] Philips N, Burchill D, O’Donoghue D,
Gonzalez S. (2001) Dermal fibroblasts convert benzene to non-phenolic compounds
that are less toxic than the phenolic metabolites of benzene. J Invest Dermatol
117: 481 (Poster: Society of Invest.
[4] Philips N and Devaney J. (2001) Hormone replacement therapy increases type I collagen in dermal fibroblasts by stimulating transforming growth factor-beta. J Am Aging 24: 129 (Poster: Annual meeting of AGE/American College of Clinical Gerontology/AFAR).
[5] Philips N, Devaney J, Smith J, Hamilton S, Gonzalez S.
(2002) Hormones, Polypodium leucotomos, and lutein, respectively,
regulate expression of extracellular matrix proteins in skin fibroblasts.
Biogerontology 3: 93 (Oral: European Congress of
[6] Philips N. (2003) Skin anti-aging and
anti-carcinogenic effects of lutein, and Polypodium leucotomos. J Am
Aging (Oral: American Aging Association,
[7] Philips
N, Keller T, Smith J, Gonzalez S. (2003) Regulation of
matrix metalloproteinases (MMPs), and tissue inhibitors of matrix
metalloproteinases (TIMPs) by anti transforming growth factor-b
antibodies, lutein and Polypodium leucotomos. Mol. Cell. Proteonomics: 2: 923 (Oral:
HUPO Annual and IUBMB World Congress,
[8]
Philips N.
(2005) Skin Firming activity of Rhodiola via induction of elastin;
Cofactors
for increased skin metabolic activity (Oral: Web conference,
[9] Philips N. (2006) The Cellular and Molecular Biology of Aging and Cancer (FDU Seminar).
[11] Philips N (2007) Regulation of the Extracellular Matrix Remodeling by Lutein
in Dermal Fibroblasts, Melanoma cells, and Ultraviolet Radiation Exposed
Fibroblasts. Cancer Drug Discovery (Poster: Drug Discovery and Development of Innovative Therapeutics,
[12] Philips
N. (2007) Semester-Long
Application-Based Investigative Project, in Modern Cell Biology, for Broader
Learning Outcomes Session (Poster: ASCB,
[13] Philips
N. (2008). Experimental Biochemistry in Anti-Skin Aging (Oral: SCC, NJ)
[14] Philips N. (2008) Anti: Skin Aging and Cancer (FDU Seminar).
[15] Philips N. (2008) Photoaging, and Cancer Treatment by Gene Silencing or
Micronutrients (Poster: Drug Discovery
and Development of Innovative Therapeutics,
[16] Philips N. (2009) Inflammation;
Immunity:Antibodies; Signaling Pathways that Control Gene Activity (Oral:
Presperse Inc,
[17] Philips N. (2009) Aging, Wound Healing and Cancer (FDU Seminar).
Research Students Presentations/Abstracts (74)
A.
Ultraviolet radiation, oxidants or/and
anti-oxidants
[1] Newman J and Philips N. (1999) Molecular correlation of ICAM-1
(intercellular adhesion molecule-1) and cellular senescence Bull NJ Acad Sci 44
[2] Clark T and
Philips N. (1999) Effect of nitric oxide on ultraviolet irradiated
keratinocytes.
[3] Golovaty E and Philips N. (1999) Say no (nitric oxide) to hydrogen peroxide
cytotoxicity in dermal keratinocytes.
[4] Newman J
and Philips N. (2000) Activity and secretion of ICAM-1 by oxidants,
antioxidants and combinations of oxidants and antioxidants, in dermal
fibroblasts.
[5] Avramidis A and Philips N. (2000) Regulation of extra cellular matrix
(ECM) proteins, growth factors and intercellular adhesion molecule-1
(ICAM-1) expressions by nitric oxide (NO)
in dermal fibroblasts
Acad Sci 45
[6] Clark T and Philips N. (2000) Effects of ultraviolet radiation and nitric oxide
(NO) in dermal fibroblasts.
[7] Avramidis A and Philips N (2001) Regulation of extra cellular matrix (ECM) proteins, growth factors and intercellular adhesion molecule-1 (ICAM-1) expressions by nitric oxide (NO) in dermal fibroblasts Bull NJ Acad Sci 46
[8] Parratt A and Philips N. (2001)
Potentiation of ultraviolet induced generation of hydrogen peroxide by TGF-b, hydrogen peroxide and a nitric oxide
scavenger.
[9] Smith J, Gonzalez S and Philips N. (2001) Antagonistic effects of ultraviolet
radiation and Polypodium leucotomos on skin keratinocytes and fibroblasts.
[10] Parratt A and Philips N. (2002) Induction of elastin expression by ultraviolet radiation in human dermal keratinocytes (Sigma Xi research symposium)
[11] Cassidy S, Karl
S, Myatt S and Philips N. (2003) Anti-aging effects of mild stress on
fibroblast cells.
[12] Covert S, David DG and Philips N. (2003) Xanthophyll and its role in aging
[13] Hamilton S
and Philips N. (2002) Effects of lutein on skin aging (Sigma Xi)
[14] Hendrix C and Philips N. (2003) Protective Effect of lutein on skin aging (Sigma Xi research symposium)
[15] Ekelhar A,
Surgent B and Philips N. (2003) Dose dependent responses of early and late
passage fibroblasts to Polypodium
leucotomos extract.
[16] Woo J and Philips N. (2007) Increased Expression of elastin in ultraviolet radiation exposed keratinocytes (Hudson-Bergen Chemical Society, SJU Sigma Xi Research Symposium)
[17] Natarajan P and Philips N. (2008) Mechanisms of skin regeneration by a mollusk secretion (Hudson-Bergen Chemical Society, FDU Bio-Seminar).
[18] Thota S, Yarlagadda S and Philips N. (2008) Large scale plasmid preparation and promoter activity testing (Hudson-Bergen Chemical Society).
[19] Yarlagadda S and Philips N. (2008) Anti skin aging effect of luteolin (Hudson-Bergen Chemical Society).
[20] Conte J, Scorfield J and Philips N. (2008) Screening activities in elastase enzyme inhibition assays (Hudson-Bergen Chemical Society).
[21] Plaskon P, Pedrick M, Fields T and Philips N. (2009) Epidermal protective effects of vitamin D (Hudson-Bergen Chemical Society).
[22] Baswan, S and Philips N. (2009) Anti-Skin aging potential of xanthohumol by
stimulation of fibrillin expression (Hudson-Bergen Chemical Society)
[23] Chauhan, S and Philips N. (2009) Regulation of heat shock proteins by p. leucotomos and its components in skin cells (Hudson-Bergen American Chemical Society).
[24] Dodiya, R and Philips N. (2009) Polyphenols stimulate structural collagens (Hudson-Bergen Chemical Society, Biology Seminar, FDU Biology Seminar).
[25] Jain, D and Philips N. (2009) Dual protective effects of p. leucotomos and its components on elastic fibers (Hudson-Bergen Chemical Society, FDU Biology Seminar).
[26] Perez E, Kogan A, Yamada E and Philips N. (2009) regulation of apoptosis for cell survival by P. leucotomos in ultraviolet radiation exposed keratinocytes (Hudson-Bergen Chemical Society).
elastin and heat shock proteins by caffeic acid (Hudson-Bergen Chemical Society, Society of Cosmetic Chemists Annual Meeting).
[28] Tuason, M and Philips N. (2009) Beneficial remodeling of the extracellular matrix by P. leucotomos and its components (Hudson-Bergen American Chemical Society).
Lung (fibroblasts)
[29] Prashanthi N and Philips N. (2007) Regulation of cell viability and matrixmetalloproteinases in lung fibroblasts by Xanthohumol (Hudson-Bergen Chemical Society, National Collegiate Honors Conference, FDU Bio-Seminar)
[30] Schmidt E, Lescisko A and Philips N. (2007) Oxidative effects of hydrogen peroxide in lung (MRC5) fibroblasts (Hudson-Bergen Chemical Society, SJU Sigma Xi Research Symposium)
Cancer (melanoma, renal,
mammary or endometrial cancer, vero)
[31]Rizzo L and Philips
N. (1999) Antioxidants affect the growth and collagenase expression of mammary
epithelial cells.
[32] Stephan K, Harpe
A, Leonard C and Philips N. (1999) Nitric oxide and its effects on 10A, 10F,
and MCF-7 cells.
[33] Carey J and
Philips N. (2001) Effects of oxidants and antioxidants on renal adenocarcinoma
cell proliferation and metastasis.
[34] Massa T, Vaccaro S, Vestyck L and Philips N. (2003) Regulation of matrixmetalloproteinases (MMP) in melanoma cells by hydrogen peroxide Bull NJ Acad Sci 47
[35] Matlosz T, Patel P, DeGregorio D and Philips N. (2003) Differential effects of hydrogen peroxide on MMP-1, MMP-2, and TGF-β mRNA levels in
renal cancer cells Bull NJ Acad Sci 47
[36] Gocek D, Wines P and Philips N. (2003) Anti-carcinogenic effects of
xanthophyll.
[37] Inzano CA, Ord L and Philips N. (2003) Dose responsive effects of
Polypodium leucotomos on MMP-1, MMP-2 and TGF-b in renal
and melanoma cells.
[38] Arena R and Philips N. (2007) Identification of anti-carcinogenic agents in the treatment of melanoma (Hudson-Bergen Chemical Society, SJU Sigma Xi Research Symposium, FDU Bio-Seminar)
[39] Pitropaki A, Aviles D and Philips N. (2007) Selective inhibition of melanoma cell viability by Polypodium leucotomos (SJU Sigma Xi Research Symposium)
[40] Kogan A, Padilla S and Philips N. (2008) Molecular mechanisms of luteolin’s anticarcinogenic effect (Hudson-Bergen Chemical Society, FDU Bio-Seminar).
B. TGF-β or
anti-TGF-b antibodies
(8
abstracts)
Skin (fibroblasts, keratinocytes)
[1] Novak K and Philips N.
(2000) Effects of anti-TGF-b
antibodies on TGF- b secretion,
extracellular (ECM) proteins and DNA apoptosis in dermal fibroblasts.
[2] Sodt R and Philips N. (2000) Effects of dioxins and anti TGF antibodies on
oxidative stress response in dermal
fibroblasts.
[3] Keller T and Philips N. (2002) Regulation of matrix metalloproteinases by anti
transforming growth factor beta in fibroblast cells (Sigma Xi research symposium)
[4] Keller T and Philips N. (2003) Regulation of matrix metalloproteinases by
anti transforming growth factor-beta antibodies in dermal fibroblasts. Bull
NJ Acad Sci 47
Lung (fibroblasts)
[5] Goldschein E and Philips N. (2007) Regulation of tissue inhibitor of matrixmetalloproteinases by transforming growth factor- beta: Modulation by ultraviolet radiation (Hudson-Bergen American Chemical Society, SJU Sigma Xi Research Symposium, FDU Bio-Seminar)
Cancer (melanoma, renal,
mammary or endometrial cancer, vero)
[6] Onwubalili N, and Philips N. (1999) Proliferative effect of the TGF-
antibodies; anti-TGF- β and anti-LAP, on immortalized human mammary
epithelial (MCF-10A) cells.
[7] Onwubalili N. and Philips N. (2000) Proliferative effect of the TGF-β antibodies, anti-TGF-β and anti-LAP, on renal adenocarcinoma cells (Tri-beta meeting presentation)
[8] Monteleone J, and Philips N. (2002) Increased cell proliferation and expression of
transforming growth factor alpha and matrix metalloproteinase–2 by anti
transforming growth factor beta (Sigma Xi
research symposium)
C. Ascorbic acid (6 abstracts)
Cancer (melanoma, renal,
mammary or endometrial cancer, vero)
[1] Slavick S and Philips N. (2000) Differential effects on hydrogen peroxide and
ascorbic acid on renal adenocarcinoma and
uterine endometrial cells.
Acad Sci 45.
[2] Carey J and Philips N (2002) Regulation of proliferation and expression of growth
factors, and matrix metalloproteinases in renal, skin, and mammary cancer
cells (Sigma Xi research symposium)
[3] Hourmouzis P, Plaskon P, McKelvey K,
Avendano A and Philips N. (2007) Ascorbate
in combination with Vitamin E in cancer treatment (Hudson-Bergen Chemical
Society, SJU Sigma Xi Research Symposium)
[4] Semilla A and Philips N. (2008) Gene silencing for photoaging and cancer therapy (Hudson-Bergen Chemical Society, FDU Bio-Seminar).
[5] Givant J and Philips N. (2008) Mechanisms regulating differential regulation of MMP1 by ascorbate (Hudson-Bergen Chemical Society, NJ Acad. Sci., Junior academy).
[6] Dulaj, L and Philips N. (2009) Combination of Vitamin C and P. leucotomos is Beneficial to Cancer Therapy (Hudson-Bergen Chemical Society, FDU Biology Seminar).
D. Ceramide (3
abstracts)
Skin (fibroblasts,
keratinocytes)
[1] Hanrahan S and Philips
N. (1999) The role of ceramide (n-acetyl d-sphingosine) in the regulation of
extracellular matrix proteins in fibroblasts.
[2] Hamilton S and
Philips N. (2001) Transcriptional regulation of oxidative stress and
collagenase genes by ceramide in keratinocytes.
[3] Lin Y, Plaskon P, Chang T and Philips N. (2008) Epidermal differentiation mechanism of ceramide (Hudson-Bergen American Chemical Society, FDU Bio-Seminar).
E. Benzene or benzene metabolites, Copper (6 abstracts)
Skin (fibroblasts,
keratinocytes)
[1] Burchill D and Philips N. (1999) Benzene metabolism by human skin cells.
[2]
O’Donoghue D and Philips N. (1999) Effect of benzene metabolites on the
toxicity and apoptosis of human dermal fibroblasts.
[3] Rosenblatt
J, Parratt A, Burchill D and Philips N. (2000) Nontoxic effects of benzene
metabolites on human dermal fibroblasts.
[4] Ryan J and
Philips N. (2001) Oxidative and aging effects of benzoic acid on dermal
fibroblasts.
[5] Ryan J and Philips N. (2002) Oxidative and aging effects of benzoic acid on dermal
fibroblasts (Sigma Xi research symposium)
[6] Kahodariya J, Mehta N and Philips N. (2008) Role of copper in wound healing (Hudson-Bergen Chemical Society, FDU Bio-Seminar).
F. Hormones (11 abstracts)
[1] McGovern A and Philips N. (1999)
The effect of estrogen on the promoter activity and expression of collagenase
in dermal keratinocyte, MCF-7 and MCF-
10F cells.
[2] Nelson M,
Lasko M, Loder C and Philips N. (1999) Effects of estrogen treatment and varied
matrix substrates on secretion of elastin, collagenase, and TGF-b by
fibroblasts, keratinocytes, and co-cultures of fibroblasts and keratinocytes.
[3] Devaney J
and Philips N. (2001) Hormone replacement therapy increases collagen expression
in human dermal fibroblasts via release of active TGF-β.
Cancer (melanoma, renal, mammary or endometrial cancer, vero)
[4] McFadden K and
Philips N. (1999) Effect of prolactin on the secretion of extracellular matrix
proteins in immortalized and neoplastic mammary cells.
[5] McFadden K and
Philips N. (2000) The effect of the female sex hormones prolactin and estrogen
on the secretion of MMP1 and TGF-b in both normal and turmorigenic mammary
epithelial cells.
[6]
Vorselen H and Philips N. (2000) The response of mammary cancer cells to
treatment with tamoxifen.
[7]
Stellatella J and Philips N. (2000) Effects of hormone treatment on cell
proliferation and production of growth factors and collagenase in normal and
carcinogenic endometrial cells.
[8]
Stephan K and Philips N. (2000) Regulation of interstitial collagenase promoter
activity by tamoxifen in normal uterine endometrial cells.
[9] Hurley C and
Philips N. (2001) Beneficial effects of hormone replacement therapy on
endometrial cells.
[10] Monteleone J and Philips N. (2001) Combination of estrogen and prolactin increases matrix
metalloproteinase-2 by inhibiting TGF-b
in mammary epithelial cells.
[11] Lee S and Philips N. (2008) Tamoxifen’s effectiveness in endometrial cells (Hudson-Bergen Chemical Society).
V. Courses Taught. UG: Undergraduate. GR: Graduate
Cell Biology(lecture and laboratory) (UG): Modern Cell Biology investigates the central concept for cellular functioning, DNA to RNA to Protein, by integrating biomolecules, biotechnology, regulating mechanisms, signals and signaling pathways and aberrations that result in pathology, such as cancer. Application of cell/molecular biology methodology to a research project: to examine regulation of cell viability/proliferation, toxicity, proteins, mRNA and gene activity via guided experiments for each regulatory level as well as independent experimental planning and performance. Reinforcement of concepts/applications through problem-solve tests and industry style reports, and comprehensive synthesis/communication in the format of a journal article and an oral presentation.
Biochemistry I and II (lecture and laboratory) and Topics in
Biochemistry (lecture) (UG): Structure and function of DNA, RNA and
proteins, recombinant DNA technology, metabolic pathways and hormonal regulation,
signal transduction and membrane dynamics, antibodies, DNA replication and
repair, RNA synthesis and modifications, protein synthesis and targeting,
prokaryotic and eukaryotic gene expression and regulation. The Topics in
Biochemistry course corresponded to research and pharmaceutical literature in
Biochemistry.
Techniques: Theories and Applications (lecture and laboratory) (UG): The goal of the course is teach
essential fundamental, advanced and current techniques in
chemistry/biochemistry and molecular biology. These techniques include handling
numbers; weighing and solution preparation; experiment designing and planning
technical process; spectrophotometry; chromatography; enzyme
kinetics/inhibition; assays for reactive oxygen species; cell culture,
hemocytometer and microscopes; agarose and polyacrylamide gel electrophoresis;
Southern and Western blotting blotting; cloning, plasmid preparation and expression
vectors in eukaryotic cells; polymerase chain reaction (PCR) and real time-PCR;
and discussion on nucleic acid arrays.
General BiologyI (lecture) (UG): encompasses two areas of studies: the diverse organisms, their organization/classification, and evolutionary history/relationship; and the architecture and functioning of organ systems that maintain body’s homeostasis.
General BiologyII (lecture) (UG): General Biology II is the foundation to cell and molecular biology. It is comprised of Molecules and Cells; Genetics; and Evolutionary Biology. It is focused on fundamental biological concepts, their development, research and scientific process.
Comprehensive synthesize and presentation of an area of the lecture, an associated methodology, and application to real life biological process - using lecture information, research articles and web-sites’ information
General BiologyII (laboratory) (UG): General Biology II laboratory is the hands-on counterpart to General Biology II lecture. The emphasis is on the scientific process / hypothesis testing, and scientific communication as abstract, introduction, methods, results, discussion and literature cited. It is comprised of experiments in Molecules and Cells; Genetics; and Evolutionary Biology.
Modern Biology (lecture) (UG): Atoms, Molecules, and Cells, Genetics, Animal Anatomy and Physiology, Energy and its Transformations, and Evolution and the Diversity of Life. Role of science in everyday life; Scientific Method; Scientific communication
Integrated Science I and II (lecture and laboratory) (UG); Integrated Science: Incorporation of the principles in biology, chemistry, physics and earth science. Topics include matter, energy, entropy, thermodynamics, electricity, magnetism, atomic and nuclear structure, chemical principles, chemical reactions, organic chemistry, biochemistry, rocks, planets, genetics, ecology, and evolution. Laboratory experiences demonstrate the principles presented in lecture.
Advanced Cell Biology (lecture and laboratory) (GR): Cell structure and function, signals, receptors and signal transduction, recombinant DNA technology and its application in biotechnology, transcription initiation and regulation, mRNA processing, gene expression and regulation, nerve cell physiology and pharmacology, cell cycle regulation and cancer
Tissue Culture(lecture and laboratory): Tissue culture applications in genetics, gene expression, intracellular activity, and secretion of cell products, cell-cell and cell-environment interactions, and tumorigenesis. Cell culture biology, primary culture, cell propagation, maintenance, and cryopreservation; quantitation and cytotoxicity; primary cell culture and cell cloning; cell differentiation and transformation; molecular techniques
Microtoxicity and Biochemistry (lecture) (GR): The underlying microtoxicity/biochemistry principles in cosmetic skin care: Fundamental concepts of bio-molecules (structure, function, expression, regulation); metabolic pathways and their integration; skin structure, inflammation, aging and diseases; active ingredients in skin cleansers and moisturizers; delivery of cosmetic products. Delineation of the microtoxicity/biochemistry of current skin care procedures, biological targets and new technology
Recombinant DNA technology (lecture) (GR): It is fundamental to molecular biotechnology that encompasses
many scientific disciplines (i.e. molecular biology, microbiology,
biochemistry, immunology, genetics, chemical engineering, cell biology) and
generates a wide range of consumer products (i.e. crops, drugs,
vaccines, diagnostics, and livestock). Topics covered are text (in syllabus,
section II) chapters : “Molecular
Biotechnology Biological Systems, Gene Regulation, Recombinant DNA
Technology, Chemical Synthesis,
Sequencing, and Amplification of DNA, Manipulation of Gene Expression in
Prokaryotes, Heterologous Protein Production in Eukaryotic cells, Directed
Mutagenesis and Protein Engineering, Molecular
Diagnostics, Therapeutic Agents, Vaccines, Synthesis of Commercial
Products by Recombinant Microorganisms, Large-Scale Production of Proteins from
Recombinant Microorganisms, Transgenic Animals, Regulating Use of Biotechnology, Patenting Biotechnology
Inventions”
Biotechniques (lecture and laboratory) (GR): Current biotechnology techniques, including DNA cloning, gene regulation and protein expression/activity, using in-vitro models as wells as prokaryotic, and eukaryotic cells or tissue-equivalents. The laboratory is the hands-on counter-part to lecture: Molecular biotechniques of wide applicability; Different biological systems used in molecular biotechnology; DNA cloning, plasmid engineering, plasmid selection and propagation; Site-directed mutagenesis, polymerase chain reaction, selection of mutants; Prokaryotic expression of protein, protein isolation and analysis by SDS-PAGE and/or Western blotting; Eukaryotic transformation of a wild type or mutant gene, genomic organization of stable transformants, and cellular localization of expressed protein; Notebook records of experiments, presentations, group discussions, manuscript preparation, and creation of a proposal for an independent experiment, via accessing and adapting a molecular technique to problem solve a research question
Genetics Workshop (high school advanced placement
biology students): Restriction enzyme digestion of DNA, gel electrophoresis,
polymerase chain reaction, and transformation to examine gene expression.
VI. Scientific Community Service
Reviewer: Manuscripts,
Textbooks, Proposals
Manuscripts:
Skin Pharmacology and Physiology
(S. KARGER AG, BASEL),
Experimental Dermatology (Blackwell Publishing)
BBA-Molecular
Cell Research (Elsevier)
British Journal of Cancer (Blackwell Publishing
Ecotoxicology and Environmental Safety (Elsevier
Current Drug Targets (Bentham Science Publishers)
Dermatology Research and Practice (Hindawi Publishers)
Clinical, Cosmetic and
Investigational Dermatology (Dove Medical Press)
The Open Biotechnology Journal
(Bentham Science Publishers)
Text Books: Academic Press/Elsevier
Go-Tutorials: Wiley
Grant Proposal: Innovational Research Incentive Scheme (Netherland Organization for Scientific Research)
Consultant or Collaborator: Presperse, Somerset, NJ; Bergen Academies, Hackensack, NJ